Tenoxicam papers
(2016) Determination of tenoxicam in the plasma by reverse phase HPLC method using single step extraction technique: a reliable and cost effective approach., Acta Poloniae Pharmaceutica 73(5), p. 1129-1134, Polish Pharmaceutical Society, pdf
(2016) Toxicological screening of human plasma by on-line SPE-HPLC-DAD: identification and quantification of acidic and neutral drugs., Biomedical Chromatography 30(3), p. 343-362, John Wiley & Sons Ltd., doi:10.1002/bmc.3554
(2013) Simultaneous determination for oxicam non-steroidal anti-inflammatory drugs in human serum by liquid chromatography-tandem mass spectrometry., Forensic Science International 227(1-3), p. 100-102, Elsevier Ltd., doi:10.1016/j.forsciint.2012.11.016
(2010) Lc-uv method development and validation for the non steroidal anti-inflammatory agent tenoxicam, Journal of Liquid Chromatography and Related Technologies 33(5), p. 720-729, doi:10.1080/10826071003609015
(2009) Enhancement of the dissolution profile of tenoxicam by a solid dispersion technique and its analytical evaluation using HPLC., Drug Discoveries & Therapeutics 3(1), p. 27-36, International Advancement Center for Medicine & Health Research Co., Ltd.
(2006) Relative bioavailability of tenoxicam capsules., Yaowu Fenxi Zazhi 26(5), p. 589-591, Yaowu Fenxi Zazhi Bianji Weiyuanhui
(2005) Simultaneous determination of piroxicam, meloxicam and tenoxicam in human plasma by liquid chromatography with tandem mass spectrometry., Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 826(1-2), p. 214-219, Elsevier B.V., doi:10.1016/j.jchromb.2005.08.023
(2003) Photophysical studies of oxicam group of NSAIDs: piroxicam, meloxicam and tenoxicam, p. 1213-1222, url
(1995) Simple method for the analysis of tenoxicam in human plasma using high-performance liquid chromatography., Journal of Chromatography B: Biomedical Sciences and Applications 665(2), p. 410-415, Elsevier, url, doi:10.1016/0378-4347(94)00534-C
(1994) Relative bioavailability of oral dosage forms of tenoxicam, Arzneim.-Forsch. 44(9), p. 1051-1054, Cantor
(1993) Bioavailability of intramuscularly administered tenoxicam, Biopharmaceutics & Drug Disposition 14(6), p. 483-490, John Wiley & Sons, Ltd., url, doi:10.1002/bdd.2510140604
(1992) Determination of Tenoxicam in Human Plasma using Solid-Phase Extraction and High-Performance Liquid Chromatography with Ultraviolet Detection, Journal of Liquid Chromatography 15(4), p. 683-695, Taylor & Francis, url, doi:10.1080/10826079208018826
(1990) Binding of drugs in milk: the role of casein in milk protein binding., Pharmaceutical research 7(6), p. 633-7, pubmed, doi:10.1023/a:1015826413335
(1989) Effect of age on the pharmacokinetics of tenoxicam in comparison to other non-steroidal anti-inflammatory drugs (NSAIDs), Scand J Rheumatol Suppl 80, p. 86-89
(1989) Plasma tenoxicam concentrations after single and multiple oral doses, European Journal of Drug Metabolism and Pharmacokinetics 14(1), p. 23-27, url, doi:10.1007/bf03190838
(1988) Integrated plasma and synovial fluid pharmacokinetics of tenoxicam in patients with rheumatoid arthritis and osteoarthritis: factors determining the synovial fluid/plasma distribution ratio, Therapeutic drug monitoring 10(3), p. 250-260
(1988) The effect of concurrent aspirin upon plasma concentrations of tenoxicam., British Journal of Clinical Pharmacology 26(4), p. 455-462, doi:10.1111/j.1365-2125.1988.tb03405.x
(1987) Pharmacokinetics of Tenoxicam after oral administration in healthy human subjects of various single doses, European Journal of Drug Metabolism and Pharmacokinetics 12(1), p. 59-63, url, doi:10.1007/bf03189862
(1987) Overview on the pharmacokinetics of tenoxicam, Eur. J. Rheumatol. Inflammation 9(1-2), p. 15-25
(1986) Pharmacokinetics of tenoxicam in patients with impaired renal function, Eur J Clin Pharmacol 29(6), p. 697-701
(1986) Determination of tenoxicam in human plasma by high-performance liquid chromatography., Journal of Chromatography, Biomedical Applications 374(1), p. 95-102, url, doi:10.1016/S0378-4347(00)83256-9
(1984) Pharmacokinetics of tenoxicam in healthy human volunteers, Eur J Rheumatol Inflamm 7(2), p. 33-44
(1984) Rapid method for the determination of either piroxicam or tenoxicam in plasma using high-performance liquid chromatography., Journal of Chromatography, Biomedical Applications 310(2), p. 455-459, doi:10.1016/0378-4347(84)80116-4
Praziquantel
(2017) A quantification method for determination of racemate praziquantel and R-enantiomer in rat plasma for comparison of their pharmacokinetics, Journal of Chromatography B 1048, p. 64-69, url, doi:10.1016/j.jchromb.2017.02.013
(2016) Development and validation of an enantioselective LC-MS/MS method for the analysis of the anthelmintic drug praziquantel and its main metabolite in human plasma, blood and dried blood spots, Journal of Pharmaceutical and Biomedical Analysis 118, p. 81-88, Elsevier B.V., url, doi:10.1016/j.jpba.2015.10.011
(2015) Comparison of different pretreatment methods for determination of praziquantel in rabbit plasma by HPLC., Xumu Yu Shouyi 47(2), p. 81-84, Xumu Yu Shouyi Zazhishe
(2015) Simultaneous determination of praziquantel, pyrantel embonate, febantel and its active metabolites, oxfendazole and fenbendazole, in dog plasma by liquid chromatography/mass spectrometry., Biomedical Chromatography 29(12), p. 1859-1865, John Wiley & Sons Ltd., doi:10.1002/bmc.3507
(2014) Determination of praziquantel in rabbit plasma by high performance liquid chromatography-tandem mass spectrometry., Fenxi Shiyanshi 33(3), p. 269-272, Fenxi Shiyanshi Bianjibu, doi:10.13595/j.cnki.issn1000-0720.2014.0061
(2010) Determination of plasma praziquantel in dog by HPLC., Zhongguo Shouyi Zazhi 46(9), p. 84-86, Zhongguo Nongye Daxue Chubanshe
(2009) Enantioselective analysis of praziquantel and trans-4-hydroxypraziquantel in human plasma by chiral LC–MS/MS: Application to pharmacokinetics, Journal of Chromatography B 877(27), p. 3083-3088, Elsevier, url, doi:10.1016/J.JCHROMB.2009.07.036
(2007) Simultaneous determination of albendazole metabolites, praziquantel and its metabolite in plasma by high-performance liquid chromatography–electrospray mass spectrometry, Journal of Pharmaceutical and Biomedical Analysis 44(2), p. 558-563, url, doi:10.1016/j.jpba.2006.11.020
(2004) A high-performance liquid chromatographic method for determination of praziquantel in plasma, Journal of Pharmaceutical and Biomedical Analysis 36(4), p. 871-876, Elsevier, url, doi:10.1016/J.JPBA.2004.07.043
(2002) LC determination of praziquantel in human plasma, Journal of Pharmaceutical and Biomedical Analysis 28(1), p. 181-186, Elsevier Science B.V., url, doi:10.1016/S0731-7085(01)00605-7
(1997) Enantioselective analysis of praziquantel in plasma samples., Journal of Chromatography B: Biomedical Sciences and Applications 696(2), p. 307-311, Elsevier
(1995) High-Performance Liquid Chromatographic Determination of Praziquantel in Plasma and Tissues of Cultured Fish for Residue and Pharmacokinetic Studies, Journal of Liquid Chromatography 18(3), p. 589-597, Taylor & Francis Group , url, doi:10.1080/10826079508009259
(1993) Sensitive high-performance liquid chromatographic assay for praziquantel in plasma, urine and liver homogenates, Journal of Chromatography B: Biomedical Sciences and Applications 613(1), p. 174-178, Elsevier, url, doi:10.1016/0378-4347(93)80213-N
(1989) Determination of the concentration and pharmacokinetic parameters of praziquantel in the cerebral spinal fluid of cerebral cysticercosis patients by high performance liquid chromatography., Sepu 7(2), p. 75-77
(1984) Spectrofluorimetric determination of praziquantel in rabbit plasma. | Analytical Abstracts, Yaowu Fenxi Zazhi 4, p. 144-147, url
(1984) Spectrofluorometric determination of praziquantel in rabbit plasma., Yaowu Fenxi Zazhi 4(3), p. 144-147
(1979) A Fluorometric method for the determination of praziquantel in blood-plasma and urine, European Journal of Drug Metabolism and Pharmacokinetics 4(3), p. 143-148, url, doi:10.1007/BF03189417